Welcome to our dedicated page for U S Physical Therapy SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how clinic visit volumes, payer mix, and therapist partnership incentives shape U.S. Physical Therapy鈥檚 cash flow can feel overwhelming. When reimbursement tables are buried deep inside a 300-page report, even seasoned analysts struggle to find answers鈥攅specially if they just want U.S. Physical Therapy SEC filings explained simply.
StockTitan solves that problem. Our AI reads every U.S. Physical Therapy annual report 10-K simplified, flags changes in segment margins inside each U.S. Physical Therapy quarterly earnings report 10-Q filing, and streams U.S. Physical Therapy Form 4 insider transactions real-time. Need context on an unexpected acquisition? We surface the corresponding U.S. Physical Therapy 8-K material events explained alongside plain-English summaries. Prefer raw numbers? Download exhibits without digging through EDGAR.
- Instant alerts for U.S. Physical Therapy insider trading Form 4 transactions
- Side-by-side comparison of clinic metrics across quarters鈥攑erfect for U.S. Physical Therapy earnings report filing analysis
- Highlights of salary, bonus, and option grants pulled from the latest U.S. Physical Therapy proxy statement executive compensation
- Contextual pop-ups that make understanding U.S. Physical Therapy SEC documents with AI effortless
Whether you鈥檙e monitoring U.S. Physical Therapy executive stock transactions Form 4 before a new clinic rollout or checking covenant compliance after a debt refinancing, our real-time feed and AI-powered summaries give you the insight you need鈥攚ithout wading through endless footnotes.
Gevo, Inc. (GEVO) 鈥� Form 144 filing
An insider intends to sell up to 11,694 common shares through broker Stifel Nicolaus on or about 1 Aug 2025. The stock block is valued at $14,992, implying an estimated price of roughly $1.28 per share. With 239.56 million shares outstanding, the proposed sale equates to less than 0.005 % of total float, signalling negligible dilution risk.
The filer received 22,962 shares on 26 Jul 2025 via restricted-stock units and has already disposed of 23,994 shares for $30,760 during the past three months. By signing, the seller affirms no possession of undisclosed adverse information. The filing is a notice only; it neither guarantees execution nor conveys new fundamental data about Gevo鈥檚 operations.
While routine, repeated insider sales can influence sentiment, the size and value of this transaction are immaterial to the company鈥檚 capital structure.
Copeland Capital Management, LLC, an investment adviser organized in Delaware, has filed a Schedule 13G indicating that it now holds a beneficial ownership of 676,795 shares of US Physical Therapy, Inc. (USPH) common stock, representing 5.85 % of the outstanding class as of 30 June 2025.
The firm reports:
- Sole voting power: 583,323 shares
- Shared voting power: 156,873 shares
- Sole dispositive power: 583,323 shares
- Shared dispositive power: 156,873 shares
This disclosure signals that Copeland has crossed the 5 % reporting threshold, giving investors insight into evolving institutional ownership levels in USPH.
U.S. Physical Therapy, Inc. (NYSE: USPH) filed a Form 8-K dated July 1, 2025 under Item 7.01 (Regulation FD Disclosure). The company reports that Barrington Research Associates, Inc. released a research report on the same day that contains information attributed to USPH management. That report is furnished as Exhibit 99.1. In accordance with SEC rules, the company specifies that the material is being furnished, not filed; therefore it is not subject to Section 18 liability and is not incorporated by reference into Securities Act filings. No financial statements, earnings figures, transactions, or guidance updates accompany this filing.
FAQ
What is the current stock price of U S Physical Therapy (USPH)?
What is the market cap of U S Physical Therapy (USPH)?
What is the primary service offering of U S Physical Therapy Inc?
How does the therapist partnership model benefit the company?
What types of treatment services are provided by USPH clinics?
How does USPH diversify its revenue streams?
What distinguishes USPH in the competitive healthcare market?
How does the company ensure high-quality clinical services?
